Author

Nimra Shafi

3 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Open access Oct 2026

Comparative LDL-C Reduction and Cardiovascular Outcomes With PCSK9-Pathway Therapies: A Systemic Review and Network Meta-Analysis

Proprotein convertase subtilisin/kexin type 9 (PCSK9)–targeted therapies substantially reduce low-density lipoprotein cholesterol (LDL-C) and cardiovascular risk. While monoclonal antibodies have demonstrated outcome benefits, newer agents including siRNA and small-protein inhibitors lack mature event-driven data...

H. Ramteke, R. Khan, N. Shafi et al. · European Heart Journal · 0 citations

Open access Oct 2026

A multimodal explainable ai model integrating electrocardiographic signatures and left atrial strain to predict atrial fibrillation recurrence after catheter ablation

Atrial fibrillation (AF) recurrence after catheter ablation remains common and inadequately predicted by conventional clinical scores. Electrical remodeling captured by ECG and structural remodeling reflected by left atrial strain may provide complementary risk information. We aimed to develop an explainable mult...

H. Ramteke, R. Khan, N. Shafi et al. · European Heart Journal · 0 citations

Review Open access Sep 2026

Cardiovascular outcomes of oral incretin-based drugs in type 2 diabetes: a GRADE-assessed meta-analysis of 67,679 patients

Background While injectable GLP-1 receptor agonists like semaglutide have demonstrated clear cardiovascular benefits in type 2 diabetes mellitus (T2DM), the role of oral incretin-based therapies, including oral semaglutide and DPP-4 inhibitors—remains less well defined. Comprehensive evaluation of their cardiovascular...

M. F. Ali, O. Mohammed, Amina Suhail et al. · Frontiers in Cardiovascular... · 0 citations